# Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469

> **NCT01971502** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 68 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo to BI 1060469
- **DRUG:** BI 1060469
- **DRUG:** BI 1060469

## Key facts

- **NCT ID:** NCT01971502
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2014-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01971502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01971502, "Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01971502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*